MedPath

Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis

Not Applicable
Terminated
Conditions
Knee Osteoarthritis
Interventions
Device: Durolane
Device: PBS
Registration Number
NCT01753830
Lead Sponsor
Galderma R&D
Brief Summary

The purpose of the study is to determine whether a single intra-articular injection of Durolane 4.5 mL is superior to a single injection of PBS 4.5 mL for the relief of joint pain in patients with osteoarthritis of the knee.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Body Mass Index (BMI) ≤ 35 kg/m2
  • Symptomatic osteoarthritis (OA) of the knee
  • K L severity grade 1 or 2
  • If bilateral OA, contralateral knee K L severity grade 0 or 1
Exclusion Criteria
  • Has clinically apparent tense effusion of the index knee
  • Has had surgery on the symptomatic knee within the previous 12 months or arthroscopy in the index knee in the past 3 months
  • Has any painful orthopedic disorders of the back or hip
  • Has a joint disorder other than osteoarthritis in the index knee

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DurolaneDurolaneSingle intraarticular injection of Durolane
PBSPBSSingle intraarticular injection of PBS
Primary Outcome Measures
NameTimeMethod
Average Change in WOMAC VAS Pain Score From Week 6 to Week 30Up to 30 weeks

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain score (0-100 mm Visual Analogue Scale (VAS)). Lower score mean less pain.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath